Stockreport

ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company

EOM PHARMACEUTICAL HLDNGS  (IMUC) 
NASDAQ:AMEX Investor Relations: investors.imuc.com